FREMONT, Calif., April 2, 2019 /PRNewswire/ -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), announced today that the U.S. Food and Drug Administration (FDA) has cleared its ...
Alere has issued a voluntary correction to users of the Alere INRatio and INRatio 2 PT/INR Monitor system of certain medical conditions that should not be tested with the system (INRatio Monitor ...
Alere Inc will be initiating a voluntary withdrawal of the Alere INRatio and INRatio2 prothrombin time/international normalized ratio (PT/INR) monitoring system because of the potential for the ...
Alere has announced that its point-of-care INRatio and INRatio2 PT/INR Monitoring System, which was used to measure coagulation levels in the ROCKET AF trial, will be withdrawn from the market ...
FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense® PT/INR ...
My doctor has approved use of the Phillips Self Testing PT/INR machine. Medicare will pay 80 percent of the test strip cost. Does TRICARE cover PT/INR self testing? Thank you. Anna G. Via the Internet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results